X0306 4 2021-04-30 0 0001719395 Eargo, Inc. EAR 0001756338 Pardo Geoff C/O GILDE HEALTHCARE PARTNERS 222 THIRD STREET, SUITE 1321 CAMBRIDGE MA 02142 1 0 0 0 Common Stock 2021-04-30 4 S 0 24995 56.16 D 3098227 I See footnote Common Stock 2021-04-30 4 S 0 54586 56.84 D 3043641 I See footnote Common Stock 2021-04-30 4 S 0 24950 57.53 D 3018691 I See footnote Common Stock 2021-05-03 4 S 0 17834 54.37 D 3000857 I See footnote Common Stock 2021-05-03 4 S 0 1558 55.36 D 2999299 I See footnote Common Stock 2021-05-03 4 S 0 2163 56.65 D 2997136 I See footnote Common Stock 2021-05-03 4 S 0 450 57.14 D 2996686 I See footnote The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $55.38 to $56.37, inclusive. The Reporting Person undertakes to provide to Eargo, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. These shares are held directly by Cooperatieve Gilde Healthcare V U.A. ("Gilde"). Gilde is managed by Gilde Healthcare V Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. The Reporting Person is a partner of Gilde. The reporting person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $56.38 to $57.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $57.38 to $57.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $53.95 to $54.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $55.00 to $55.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $56.13 to $57.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. /s/ Geoff Pardo 2021-05-04